移植免疫生物学:许多答案引发了更多的问题
Mihai Oltean1,2
1The Transplant Institute, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
International journal of molecular sciences
|August 26, 2023
概括
移植免疫学并发症带来了诊断和治疗方面的挑战. 解决这些问题对于改善器官,细胞或组织移植后的患者结果至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
背景情况:
- 免疫学并发症是移植的重要障碍.
- 这些并发症的诊断和治疗仍然具有挑战性.
研究的目的:
- 探索移植后诊断和治疗免疫学并发症的挑战.
- 识别移植接受者管理的潜在改进领域.
主要方法:
- 对移植免疫学现有文献的综述.
- 分析当前的诊断和治疗策略.
- 识别知识缺口和未来的研究方向.
主要成果:
- 当前的诊断工具可能无法完全捕捉免疫反应的复杂性.
- 治疗策略通常面临有效性和特异性的局限性.
- 需要新的方法来管理移植对宿主疾病和排斥.
结论:
- 需要在了解移植免疫学方面取得进展.
- 开发更精确的诊断和治疗干预措施至关重要.
- 改进的管理协议可以提高长期的移植成功.
相关概念视频
Cell-mediated Immune Responses
68.9K
Overview
68.9K
Tissue Transplantation
396
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
396
Kidney Transplant I: Introduction
29
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360


